DALLAS, Texas - Today’s Trade Alerts include: AtheroGenics Inc. (Nasdaq: AGIX), Acme Packet Inc. (Nasdaq: APKT), BioScrip Inc. (Nasdaq: BIOS), NovaMed Inc. (Nasdaq: NOVA), Conexant Systems Inc. (Nasdaq: CNXT) and Chordiant Software Inc. (Nasdaq: CHRD).
“AtheroGenics Inc. (AGIX) shares surged nearly 53% to 84 cents yesterday, dropping 7% to 74 cents Friday morning. Yesterday’s activity followed the company’s announcement that both doses of its experimental drug, AGI-1067, met the main goal in a late-stage trial to treat type 2 diabetes to reduce blood sugar levels. AtheroGenics, a research-based pharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of chronic inflammatory diseases, including diabetes and coronary heart disease...
“In a trial dubbed ANDES, AtheroGenics studied two doses of the drug, 75 mg and 150 mg, given once daily over six months to patients with type 2 diabetes compared to placebo…
“The company said it observed regional variation in the placebo arm, where patients in Eastern Europe showed a significant decrease of blood sugar levels in the placebo arm. AtheroGenics said it will continue to analyze the trial data, including the impact of regional differences, and will conduct an additional trial as part of the development plan with the U.S. Food and Drug Administration...”
“Acme Packet Inc. (APKT) shares climbed 4% to $5.05 Friday morning. Acme Packet provides session border controllers (SBC) that enable service providers to deliver interactive communications voice, video and multimedia sessions across Internet protocol (IP) network borders…
“The company recently announced it will release financial results for the second quarter ended June 30, 2008, on Thursday, August 7, 2008, after the market closes. The company’s management team plans to host a live conference call and Web cast at 5 p.m. (ET) on the same day to discuss the financial results as well as management’s outlook for the business…”
Investors can view all of the TraderNotes and investment articles for free by visiting:
http://www.beaconequity.com/m
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of Atherogenics Inc. (Nasdaq: AGIX). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (“Beacon”) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
